SCD and X-linked adrenoleukodystrophy: Moreover, given the detrimental impact of SCD1 deficiency on X-ALD, careful consideration of cell- and tissue-specific effects, along with disease- and context-dependent differences, is essential for advancing the clinical application of SCD1 modulators.